In a large scale of clinical blood samples from cancer patients, plasma Netrin-1 levels are significantly higher in breast, renal, prostate, liver, meningioma, pituitary adenoma, and glioblastoma cancers than it in controls (Ramesh et al., 2011). This evidence concerns the gene NTN1 and cancer.